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Abstract
Background: p53 abnormality and aneuploidy often coexist in human tumors, and tetraploidy is considered as an
intermediate between normal diploidy and aneuploidy. The purpose of this study was to investigate whether and how p53
influences the transformation from tetraploidy to aneuploidy.
Principal Findings: Live cell imaging was performed to determine the fates and mitotic behaviors of several human and
mouse tetraploid cells with different p53 status, and centrosome and spindle immunostaining was used to investigate
centrosome behaviors. We found that p53 dominant-negative mutation, point mutation, or knockout led to a 2, 33-fold
increase of multipolar mitosis in N/TERT1, 3T3 and mouse embryonic fibroblasts (MEFs), while mitotic entry and cell death
were not significantly affected. In p53
-/- tetraploid MEFs, the ability of centrosome clustering was compromised, while
centrosome inactivation was not affected. Suppression of RhoA/ROCK activity by specific inhibitors in p53
-/- tetraploid MEFs
enhanced centrosome clustering, decreased multipolar mitosis from 38% to 20% and 16% for RhoA and ROCK, respectively,
while expression of constitutively active RhoA in p53
+/+ tetraploid 3T3 cells increased the frequency of multipolar mitosis
from 15% to 35%.
Conclusions: p53 could not prevent tetraploid cells entering mitosis or induce tetraploid cell death. However, p53
abnormality impaired centrosome clustering and lead to multipolar mitosis in tetraploid cells by modulating the RhoA/
ROCK signaling pathway.
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Introduction
Aneuploidy, the condition in which a cell has extra or missing
chromosomes, is the most common characteristic of human
cancers and is linked to the progressive development of high-
grade, invasive tumors. Despite this crucial role, its origins remain
elusive. A long-standing hypothesis is that a genetically metastable
tetraploid intermediate could facilitate the development of
aneuploid malignancies [1,2,3]. This assumption is supported by
researches in both cultured cells [4] and animal models [5].
Furthermore, some studies demonstrate that tetraploidy arises as
an early step in tumorigenesis where its presence is associated with
the inactivation of the tumor suppressor p53. This precedes the
formation of aneuploid cells [6,7,8]. Further support comes from
the observation that p53
-/- tetraploid mouse mammary epithelial
cells (MMECs) induced malignant mammary epithelial cancers
after subcutaneous injection into nude mice, while p53
-/- diploid
and p53
+/+ tetraploid MMECs did not [9].
p53 may regulate the level of tetraploidy and/or its deleterious
effects through multiple mechanisms. First, it has been shown that
loss of p53 facilitates spontaneous generation of tetraploid cells in
various mouse and human cell lines in culture [10,11]. Second,
p53 could influence the fate of tetraploid cells once formed. It is
reported that p53 induced apoptosis of tetraploid cells in cultured
cancer cell lines and primary mouse mammary epithelial cells
[12,13]. It has been suggested that there might be a p53 related
tetraploidy checkpoint that could permanently block the prolifer-
ation of tetraploid cells [4,14,15]. However, this assumption has
been increasingly contested by other findings that show this
inhibition could be a side effect of drugs used to induce tetraploidy
[16,17]. Third, p53 may influence the survivability of cells with
extra centrosomes, such as tetraploid cells and part of their
daughter cells. One research showed that the descendant cells
from p53
-/- HCT116 tetraploidy have a higher proportion of cells
with extra centrosomes than that from p53
+/+ HCT116
tetraploidy after a long time culturing, which induced more
multipolar mitosis in p53
-/- cells [18]. Another study showed that
p53-driven apoptosis occurs as a checkpoint mechanism to prevent
accumulation of cells with extra centrosomes [19].
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could lead to multipolar mitosis and aneuploidy and thereby
contribute to clonal evolution. This notion has been recently
validated experimentally [20]. However, cells with supernumerary
centrosomes, such as tetraploid cells, could maintain bipolar
spindles by two strategies: 1) Inactivation of extra centrosomes
making them unable to organize microtubules; 2) clustering of
extra centrosomes into two microtubule organizing centers [21].
To identify comprehensively genes required for suppressing
multipolar mitoses, genome-wide RNAi screens were performed
in Drosophila S2 cells and oral squamous cell carcinoma cell line
SCC114 [22,23]. Three groups of proteins were discovered by
these studies. The first group proteins contains members of the
spindle assembly checkpoint (SAC) required for ensuring adequate
time for converting to a bipolar spindle prior to anaphase. The
second group of proteins contains microtubule-binding proteins
with roles in spindle pole focusing. The third group contains
proteins involved in the organization and regulation of the actin
cytoskeleton, such as the formin Form3/INF2 and GTPases. The
Rho family of GTPases, key regulators of actin cytoskeleton
reorganization, has been implicated in different stages of tumour
progression. For example, constitutively active Rho GTPases can
cause cell transformation [24]. Further investigations have shown
that activated Rho GTPases induce tumour development in
experimental mouse models [25], and activation of RhoA
contributes to distant lung metastasis in vivo [26]. However,
genes encoding Rho GTPases have rarely been found mutated in
human cancers, where it seems that their activities are deregulated
[27,28,29,30]. This suggests that alterations of other genes might
account for the functional modifications of Rho GTPases which
accompany actin cytoskeleton remodeling during the neoplastic
process. As an example, mutant p53 or loss of p53 induces
overactivation of RhoA [31,32,33,34,35]. In this study, we have
demonstrated that overactivated RhoA accounted for increased
multipolar mitosis in p53 abnormal tetraploid cells, through
impairing the ability of centrosome clustering. This provides an
alternative explanation for arising of aneuploidy during tumor
initiation and the frequently observed coexistence of p53
abnormalities, genomic instability and aneuploidy in human
tumors.
Results
p53 abnormality has limited effect on the fates of
tetraploid cells
We examined the effects of p53 on the fates of tetraploid cells by
long-term live cell imaging of cells with different p53 status. We
first tracked cell proliferation in a human colon cancer cell line
HCT116 (wild type p53), a human non-small cell lung carcinoma
cell line H1299 (p53 null) and a human cervical cancer cell line
HeLa (p53 inactivated by E6) (from the IARC TP53 Database,
URL: http://www-p53.iarc.fr). To better visualize the cell nuclei,
all cell lines were transfected with a eukaryotic expression plasmid
encoding a mCherry fluorescent protein- H2B fusion protein.
After the induction of binucleated cells with cytochalasin B (Cyto-
B), live cell imaging on these cells was conducted. As shown in
Fig. 1A, 9163% of binucleated HCT116 cells, 8964% of
binucleated H1299 cells and 8666% of binucleated HeLa cells
entered mitosis. Therefore, most binucleated cancer cells could
enter mitosis, irrespective of the status of p53. These cancer cells
are of different origins and have different genetic backgrounds,
and they may have defective signaling pathways, so the results
from experiments using these cells may not be comparable. Thus,
we used N/TERT-1, a primary diploid human keratinocytic cell
line immortalized with telomerase [36,37], and the p53 defective
counterpart N/TERT-1 p53DD over-expressing dominant nega-
tive p53 [36]. After treatment with Cyto-B for 24 h, their mitotic
capacity was investigated by live cell imaging. We observed that
9265% of N/TERT-1 binucleated (tetraploid) cells and 9262% of
N/TERT-1 p53DD binucleated (tetraploid) cells entered mitosis by
the end of the movie.The remaining cellsarrested ininterphaseand
cell death was not observed (Fig. 1B). To avoid any further concerns
about the peculiarities of immortalized cell lines during the long
term in vitro culture, we turned to primary mouse embryonic
fibroblasts (MEFs) and their p53-deficient counterparts (p53
-/-
MEFs). With 0.5 mg/ml Cyto-B treatment for 12 h, 30,40% of
MEFs were binucleated (tetraploidy). We observed that 8864% of
p53
+/+ and 9465% of p53
-/- MEF tetraploid cells entered mitosis
(Fig.1C).Theproportion ofarrested cellsinp53
+/+andp53
-/-MEF
tetraploid cellswere863%and 466%,respectively.Only463%of
p53
+/+and261%ofp53
-/-MEFtetraploidcells died, and itwasnot
significantly different (p.0.05, 262 x
2 test). To investigate the
effects of p53 on the cell cycle in the tetraploid population, we
plotted the proportions of tetraploid cells entering mitosis against
time. The p53
+/+ MEF tetraploid cells were found to have the same
dynamicsasp53
-/-MEFtetraploidcellsinenteringmitosis(Fig.1D).
These results provide a functional demonstration that p53 did
not significantly influence the fate of tetraploid cells especially has
no effect on cell death.
p53 abnormality promotes multipolar mitosis of
tetraploid cells
As most tetraploid cells (.86%) could enter mitosis even in p53
normal cells, we next investigated the mitotic polarity of p53
normal and abnormal tetraploid cells which is strongly correlated
to the genesis of aneuploidy (Fig. 2A,B,C,D). As shown in Fig. 2E,
multipolar mitosis occurred much more frequently in binucleated
cells with defective p53 (9062% for HeLa and 6866% for H1299)
than in p53 normal binucleated cells (2965% for HCT116). In N/
TERT-1 tetraploid cells, disruption of normal p53 function by p53
mutant resulted in a significant increase in the incidence of
multipolar mitosis (Fig. 2F, 4763% vs. 1265%, p,0.05, 262 x
2
test). p53
-/- MEF tetraploid cells also showed a significant increase
in the incidence of multipolar mitosis (3368%) compared to the
p53
+/+ counterparts (162%) (Fig. 2G, p,0.001, 262 x
2 test).
Amino acid residue 175 is one of the most frequently mutated sites
of the p53 protein. We then asked whether p53 R175H could also
promote multipolar mitosis in tetraploid cells. Given that primary
MEFs are hard to be transfected, we turned to NIH 3T3 cells, a
murine fibroblast cell line with normal p53 protein (Fig. S1) [38].
We found that induction of a p53 R175H-GFP fusion protein in
3T3 cells significantly increased the proportion of multipolar
mitosis (3263% vs. 1861% for cells expressing GFP only
(p,0.001, 262 x
2 test, Fig. 2H)) in tetraploid cells. Thus, these
observations indicate that abnormalities of p53 promote multipo-
lar mitosis in tetraploid cells.
p53 deficient tetraploid cells are defective in clustering
extra centrosomes
Theoretically, centrosome clustering and centrosome inactiva-
tion could be alternative mechanisms allowing cells with extra
centrosomes, such as tetraploid cells, to maintain bipolar mitosis
[21,39]. To investigate multipolar mitosis in p53 abnormal
tetraploid cells, we studied centrosome behaviors at metaphase
in tetraploid cells. We identified centrosomes by immunostaining
c-tubulin and mitotic spindles using a-tubulin. We used three
parameters, C value (the number of centrosomes/the number of
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number of spindle poles) and I value (the number of inactivated
centrosomes/total number of centrosomes), to indicate the ability
of maintaining bipolar spindle, clustering extra centrosomes and
inactivating extra centrosomes of a cell, respectively. We observed
that 3662% HCT116 tetraploid cells displayed multipolar
spindles, in HeLa tetraploid cells the percentage was 9362%. In
p53
-/- tetraploid MEFs, 4864% were multipolar, compared to
1262% in p53
+/+ tetraploid MEFs (Fig. 3E, p,0.001, 262 x
2
test), consistent with previous results from live cell imaging. We
found that both centrosome clustering and centrosome inactiva-
tion existed to sustain bipolar spindle in tetraploid MEFs
(Fig. 3A,B,C,D). 93.761.6% of p53
+/+ tetraploid MEFs displayed
centrosome clustering while only 73.065.2% of p53
-/- counter-
parts did the same so. Moreover, p53
-/- tetraploid MEFs had
much a higher proportion of cells without clustered or inactivated
centrosomes than p53
+/+ tetraploid MEFs (Table 1). However, the
proportion of cells with centrosome inactivation was similar,
26.168.5% in p53
+/+ tetraploid MEFs and 28.862.4% in p53
-/-
counterparts. C value and Cl value in p53
+/+ MEFs were
significantly higher than those in p53
-/- MEFs (C value
2.0660.60 vs. 1.7460.59; Cl value 1.9060.58 vs. 1.6060.59;
p,0.001, t-test, Table 2), indicating that the ability to cluster extra
centrosomes was impaired when p53 was lost. The I value was
similar in MEF cells with different p53 genotypes, indicating that
p53 was not involved in centrosome inactivation. To investigate
more precisely the centrosome behavior in tetraploid cells of
different p53 genotype, we only compared tetraploid cells with
four centrosomes at metaphase. These p53
-/- tetraploid MEFs
displayed much more multipolar spindles than p53
+/+ tetraploid
MEFs (data not shown), losing the ability to cluster rather than
inactivate extra centrosomes (Table S1, S2).
Collectively, these results indicate that loss of p53 function
decreases the frequency of centrosome clustering and promotes
multipolar mitosis in tetraploid cells.
Over-activated RhoA contributes to multipolar mitosis in
p53 deficient tetraploid cells
We next studied the mechanism by which p53 deficiency
impairs the clustering of extra centrosomes and promotes
multipolar mitosis in tetraploid cells. Recent studies have identified
the critical roles of the actin cytoskeleton and its regulators, such as
GTPases, in suppressing multipolar mitoses in cells with extra
centrosomes [22]. In our study, the level of the activated form of
RhoA, a GTPase, in p53
-/- MEFs was significantly higher than
that in p53
+/+ MEFs (Fig. 4A). Moreover, fluorescent Phalloidin-
TRITC staining showed disorder of actin cytoskeleton in p53
-/-
MEFs (Fig. S2), which could result from over-activated RhoA
[31,40]. It was reported that expression of epithelial cell
transforming sequence 2 (ECT2), a guanine nucleotide exchange
Figure 1. Effect of p53 on the fates of tetraploid cells. Cells were treated with Cyto-B to obtain tetraploid cells. After washing, cells were
cultured in drug-free culture medium, and then tracked by live cell imaging. (A, B, C) Fates of tetraploid cells were detected by live cell imaging of
cells with different p53 status in 3 (A), 2 (B), 5 (C) independent experiments. n, the number of cells analyzed. (D) p53 could not delay mitosis of
tetraploid MEFs. Representative time course of entering mitosis of p53
+/+ and p53
-/- tetraploid cells from one experiment are shown.
doi:10.1371/journal.pone.0027304.g001
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showing examples of: (A) Bipolar mitosis of a tetraploid HCT116 cell; (B) Multipolar mitosis of a tetraploid HCT116 cell; Chromosomal material is
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Consistent with this report, quantitative-PCR analysis showed that
ECT2 mRNA levels is much higher in p53
-/- than p53
+/+ MEFs
(data not shown). The protein expression of ECT2 was also
detected to be higher in p53
-/- than in p53
+/+ MEFs, and
knockdown of ECT2 in p53
-/- MEFs significantly reduced the
activity of RhoA (Fig. 4A), corroborating that p53 could suppress
RhoA activity via transcriptional regulation of ECT2 expression.
We then assessed whether RhoA could influence the mitotic
polarity of tetraploid cells. We studied the mitosis of tetraploid
p53
-/- MEFs by live cell imaging after inhibition of RhoA activity
using cell permeable C3 transferase. C3 transferase treatment
suppressed multipolar mitoses in a concentration-dependent
fashion in p53
-/- tetraploid MEFs (Fig. 4C). After treatment with
0.5 mg/ml of C3 transferase, multipolar mitoses decreased from
3667% to 2065% (Fig. 4C, p,0.001, 262 x
2 test). However,
when activity of RhoA was suppressed by 1 mg/ml C3 transferase,
the percentage of multipolar mitosis increased again, indicating
appropriate level of RhoA activity is essential for maintaining
bipolar mitosis in tetraploid cells (Fig. 4C). Further higher
concentration of C3 transferase (2 mg/ml) could even block the
entry of mitosis. Moreover, we found a similar concentration-
dependent V-type variation of multipolar mitosis in tetraploid
p53
-/- MEFs after inhibiting the activity of ROCK, the
downstream effector of RhoA, by the highly specific inhibitor
H1152 (Fig. 4D). After treatment with 0.5 mM H1152, multipolar
mitoses decreased from 3865% to 1765% (Fig. 4D, p,0.001,
262 x
2 test). And, when activity of ROCK was suppressed by
1 mM H1152, the percentage of multipolar mitosis increased
again. We then asked whether exogenously activated RhoA could
promote multipolar mitosis in tetraploid cells. Induction of a
constitutively active RhoA-GFP fusion protein (GFP-RhoA-Q63L,
[42,43]) in 3T3 cells significantly increased the proportion of
multipolar mitosis (3562% vs. 1561% for cells expressing GFP
only (p,0.001, 262 x
2 test, Fig. 5) in tetraploid cells.
Next, we assessed whether overactivation of RhoA affected
centrosome clustering or inactivation. We studied centrosome
behaviors at metaphase of p53
-/- tetraploid MEFs after inhibition
of RhoA activity using C3 transferase or inhibiting ROCK by
H1152. After treatment with 0.5 mg/ml C3 transferase or 0.5 mM
H1152, multipolar spindles decreased from 4863% to 2363% or
2665% (Fig. 4B, p,0.001, 262 x
2 test) respectively, which was
consistent with previous results from live cell imaging. Further
investigation showed that 73.162.3% of p53
-/- tetraploid MEFs
displayed centrosome clustering while the proportion increased
significantly after C3 transferase or H1152 treatment (86.665.3%,
81.063.5%, respectively) (Table 3, p,0.05, 262 x
2 test).
However, the proportion of cells with inactivated centrosomes
was similar, 21.562.4% in control cells and 19.763.5% after C3
transferase treatment or 25.460.9% after H1152 treatment. The
treated cells had a much lower proportion of cells without
clustered or inactivated centrosomes than untreated counterparts
(17.462.4% in control, 8.563.5%, 10.461.4% after C3 transfer-
ase or H1152 treatment, respectively, Table 3, p,0.05, 262 x
2
test). C values and Cl values in treated cells were significantly
higher than those untreated control cells (p,0.001, t-test, Table 4),
indicating that the ability to cluster extra centrosomes was
impaired when p53 was lost. In contrast, the I value was similar
between treated and untreated cells.
Taken together, our results demonstrate that overactivation of
RhoA accounts for impairment of ability to cluster extra
Figure 3. The absence of p53 promotes the formation of
multipolar spindles in tetraploid cells. p53
+/+ and p53
-/- MEF cells
cultured on glass coverslips coated with 0.1% gelatin were treated with
0.5 mg/ml Cyto-B for 12 h. After washing, cells were cultured for
additional 8 h in drug-free culture medium and subjected to
immunofluorescence detection of mitotic spindles (a-tubulin staining,
green fluorescence) and centrosomes (c-tubulin staining, red fluores-
cence). Nuclei were counterstained with DAPI (emitting in blue).
Representative images of each spindle type and C, Cl and I values are
shown respectively on down-left. (A) A bipolar spindle with two
centrosomes clustered loosely on lower pole or closely on upper pole.
(B) A bipolar spindle showing two centrosomes clustered on one pole
and one centrosome inactivated (white arrow). (C) A tripolar spindle
with two centrosomes loosely clustered on one pole. (D) A tetrapolar
spindle with one centrosome on every pole. Bar=10 mm (A-D). (E)
Analysis of spindle polarity at metaphase of cells with extra
centrosomes (* P,0.001, 262 x
2 test). Error bars are standard deviation,
from results of 3 independent experiments. n, the number of cells
analyzed.
doi:10.1371/journal.pone.0027304.g003
shown in Red. Bar=10 mm (A,B); (C) Bipolar mitosis of a tetraploid p53
+/+ MEF cell; (D) Multipolar mitosis of a tetraploid p53
-/- MEF cell. Bar=50 mm
(C,D). Time counted from cell entering mitosis is presented as h:min at top-left. Arrows point to daughter cells of bipolar mitosis (C) and tripolar
mitosis (D). (E-G) Comparisons of the percentage of the tetraploid cells with the indicated mitotic polarity between p53 normal and abnormal cells,
respectively. (H) The frequency of multipolar mitosis in tetraploid cells increased after p53 R175H expression in 3T3 cells. Mitotic polarity of cells was
examined by live cell imaging after transient transfection of indicated plasmids followed by 1.5 mg/ml Cyto-B treatment for 12 h. * P,0.001, 262 x
2
test. Error bars are standard deviation, from results of 3 (E), 2 (F), 5 (G), 3 (H) independent experiments. n, the number of cells analyzed.
doi:10.1371/journal.pone.0027304.g002
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abnormal tetraploid cells (Fig. 6).
Discussion
Aneuploidy is a key feature of most human cancer, and is
proposed to result from a metastable state of tetraploidy [2,3]. Over
half of human cancers have loss or mutation of the p53 gene
[44,45], and it has been estimated that 80% of human tumors have
defects in p53 signaling pathways [46]. There was a significant
association between p53 abnormalities and genetic instability in
human tumors [47,48]. So, whether and how p53 influences the
transformation of tetraploidy to aneuploidy is very attractive.
Given that inactivation of p53 in tetraploid cells results in
progression toward aneuploidy and tumorigenesis [9], a p53
dependent ‘‘tetraploidy checkpoint’’ which could prevent the
tetraploid cells from entering mitosis has been proposed [4,49].
On the other hand, FACS analysis showed that there are much
more apoptotic cells in nocodazole induced p53 proficient
tetraploid cells than in their p53 deficient counterparts [12,13].
However, by live cell imaging, we showed that most tetraploid cells
(.86%) could enter mitosis regardless of the status of p53, this is in
accordance with previous reports [16,17]. What’s more, we
showed that the percentage of p53 proficient and deficient
tetraploid cells entering mitosis was not significantly different,
and there was not even a p53-dependent arrest of cell cycle
(Fig. 1A,B,C,D). On the other hand, the percentage of cells
undergoing cell death in both p53
+/+ and p53
-/- tetraploid MEF
cells were low (3.7% for p53
+/+ and 1.8% for p53
-/-) and not
significantly different (p.0.05, 262 x
2 test, Fig. 1C). We never
observed cell death in tetraploid N/TERT-1 and N/TERT-1
p53DD cells during live cell imaging (Fig. 1B) and others report no
cell death in p53 normal tetraploid hepatocytes during live cell
imaging of the cells [50]. Thus, p53 per se may not impede cell
cycle or induce cell death. The previously reported ‘‘tetraploidy
checkpoint’’ and p53 dependent cell death in tetraploid cells may
be either an artifact of the relatively high concentration of
nocodazole used to induce tetraploidy or could be explained by
cell-type-specific differences. Alternatively, these apoptotic cells
detected by FACS analysis could be the daughter cells from
multipolar mitosis of p53 proficient tetraploid cells, as these
daughter cells inherited extremely disordered genome content,
which would lead to apoptosis especially in p53 proficient cells.
To induce multipolarmitosis, cellsshouldhave extracentrosomes
and deficiency of clustering/inactivating extra centrosomes [21]. As
tetraploid cells often result from cytokinesis failure, endoreduplica-
tion or cell fusion, they own doubled number of centrosomes. So,
the factors that influence centrosome clustering and inactivation are
critical for preventing multipolar mitosis in tetraploid cells. Our
research indicated that p53 deficiency impaired centrosome
clustering but not inactivation of extra centrosomes in tetraploid
cells (Table 1,2and supplemental Table S1,S2), and then promoted
multipolar mitosis. Centrosome clustering depends on centrosome
movement [22]. Some F-actin cables are concentrated around the
centrosomes and extend between the centrosomes and the cell
cortex [51]. Normal F-actin is required for centrosome movement
[51,52,53,54,55]. Myosin II is also required for centrosome
movement and positioning [56]. Thus, normal F-actin organization
and Myosin II is important for normal centrosome clustering. As
RhoA/ROCK is known to regulate actin cytoskeleton and myosin
light-chain phosphorylation [57,58,59], overactivated RhoA in
tetraploid cells with p53 abnormalities would disrupt centrosome
clustering. However, disruption of F-actin does not impair the
spindle pole integrity and spindle length [51], indicating that the
ability of centrosome to assemble and organize microtubules was
not affected, implying that overactivated RhoA induced disorga-
nized F-actin would not influence the inactivation of extra
centrosomes. Other factors could also influence multipolar mitosis.
Overactivated p38a, which usually is thought to phosphorylate and
activate p53, in p53-/- tetraploid cells is involved in multipolar
mitosis [60]. Actually, RhoA could activates p38 [61], and these
results are in accordance with our finding that overactivated RhoA
promoted multipolar mitosis. In a recent research [18], after long
time culturing, the descendant cells from p53
-/- HCT116
tetraploidy have a higher proportion of cells with centrosome
amplification than that from p53
+/+ HCT116 tetraploidy, which
induced more multipolar mitosis in p53
-/- cells. This indicated that
p53 may also influence the survivability of cells with extra
centrosomes. Actually, they found that there were overexpressed
Mos, which could promote multipolar mitosis, in some p53
-/- clones
form tetraploid cells. As overexpressed Mos could induce cell death
Table 1. Centrosome clustering was impaired in p53
-/- MEF cells with extra centrosomes.
No. of cells analyzed % (Mean ± s.d.)
Centrosome inactivation Centrosome clustering Both Neither
p53
+/+ MEF 287 26.168.5 91.365.0 21.265.8 3.861.7
p53
-/- MEF 455 28.862.4 73.065.2* 15.4+2.0 13.665.6 *
Cells were treated with Cyto-B (0.5 mg/ml) for 12 h, then released for 8 h, and stained with antibodies against c-tubulin and a-tubulin for centrosomes and
microtubules, respectively. Nuclei were stained with DAPI. Note that only cells with more than 3 centrosomes at metaphase were analyzed. The percentage of cells with
indicated mechanism was shown separately. Mean 6 s.d. from three independent experiments.
*p,0.001, 262 x
2 test, compared with MEF p53
+/+ cells.
doi:10.1371/journal.pone.0027304.t001
Table 2. Centrosome behavior of MEF cells with extra
centrosomes.
No. of cells
analyzed Mean±s.d.
C value
a Cl value
b I value
c
p53
+/+ MEF 287 2.0660.60 1.9060.58 0.0760.13
p53
-/- MEF 455 1.7460.59 * 1.6060.59 * 0.0860.14
*p,0.001, t-test, compared with MEF p53
+/+ cells.
aC value ( the number of centrosomes/the number of spindle poles) indicates
the ability of maintaining bipolar spindle in cells with extra centrosomes;
bCl value (the number of activated centrosomes/the number of spindle poles)
indicates the ability of clustering centrosomes in cells with extra centrosomes;
cI value (the number of inactivated centrosomes/the number of total
centrosomes) indicates the ability of inactivating extra centrosomes in cells
with extra centrosomes.
doi:10.1371/journal.pone.0027304.t002
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+/+ cells, all p53
+/+ cell clones and some p53
-/- cell clones
which did not overexpress Mos could not induce high incidence of
multipolar mitosis.
We showed that p53 deficiency in MEFs led to a significant up-
regulation of RhoA activity (Fig. 4A) as reported previously [31,32].
Furthermore, the knockout of p53 in HCT116 induced similar
elevation of activated RhoA, and p53 mutations in HCT116 and
U2OS also overactivated RhoA [33,34,35]. Though it is very
consensus in the literature that p53 deficiency leads to increased
levels of active RhoA, the molecular details of how this occurs varies
between studies. Both increased activity of PI 3-kinase and
upregulation of ECT2, a guanine nucleotide exchange factor for
RhoA, have been proposed to be responsible for increased levels of
active RhoA in p53 deficient cells [32,41]. Additionally, the atypical
Rho protein RhoE (or Rnd3) is a p53 target gene that opposes
activation of RhoA [62,63]. Our experiments showed that ECT2
was overexpressed in p53
-/- MEFs compared with p53
+/+ MEFs,
and knockdown of ECT2 by RNAi reduced the ability of ECT2 to
overactivate RhoA in p53
-/- MEFs (Fig. 4A). This indicates that
high level of ECT2 is responsible for the abnormal high activity of
RhoA in p53
-/- MEFs. High levels of RhoA could disrupt the
assembly of actin cytoskeleton [40]. It is likely that over-activated
RhoA could also do the same (Fig. S2) [31]. Knockdown of proteins
involved in the organization and regulation of the actin cytoskeleton
or disruption of F-actin itself could promote multipolar mitosis in
cells with extra centrosomes [22,64]. Thus, our data imply a ‘‘p53/
RhoA/F-actin’’ pathway which works to regulate multipolar mitosis
in cells with extra centrosomes. Interestingly, overinhibition of
RhoA activity also promotes multipolar mitosis (Fig. 4C,D), in line
with the report that knockdown of rho, the homolog of RhoA in
drosophila, induced multipolar mitosis in S2 tetraploid cells [22].
This indicates that appropriate activity of RhoA is required for
preventing tetraploid cells from multipolar mitosis.
The fate of tetraploid cells is important, given that the human
body contains millions of dividing cells at any time and many
abnormalities could disrupt the mitosis and lead to tetraploid cells.
Firstly, deregulation of many proteins such as deficiency of myosin
light-chain phosphorylation, overexpression of Aurora A, and
mutation/inactivation of many tumor suppressers such as APC,
BRCA1, and LATS2 could induce tetraploid cells [65,66,67,68,69].
Secondly,some virus,bacteria,entosis and nondisjunctioninmitosis
could also induce tetraploid cells [37,70,71,72]. Thirdly, DNA
damage in mitosis could also induce tetraploid cells. Activation of
the ATM and ATR dependent DNA damage response impairs
spindle assembly in mitosis, leading to the formation of disorganized
microtubuleandeventuallytetraploid cellsif the DNAdamagewere
not repaired in time [73,74]. As an intermediate, tetraploid cells
could generate aneuploid cells through either progressive chromo-
Figure 4. Over-activated RhoA contributes to multipolar spindle formation in p53
-/- tetraploid cells. (A) The endogenous RhoA activities
(RhoA-GTP) in the p53
+/+ and p53
-/- MEF cells were assayed after indicated treatment. The lysates were subject to GST-Rhotekin pull-down analysis.
The amount of RhoA-GTP was detected by Western blotting of the glutathione-agarose coprecipitated with anti-RhoA antibody and was normalized
to that of RhoA in wild-type MEFs. The results are shown as the mean 6 s.d. of three experiments. (B) The frequency of multipolar spindle at
metaphase in MEF cells with extra centrosomes reduced after treatment of 0.5 mg/ml C3 transferase or 0.5 mM H1152 for 8 h, respectively (*P,0.001,
262 x
2 test). (C) Concentration dependent suppression of multipolar mitosis in tetraploid p53
-/- MEF cells by C3 transferase, a cell permeable RhoA
inhibitor. (D) Concentration dependent suppression of multipolar mitosis in tetraploid p53
-/- MEF cells by H1152, a cell permeable ROCK inhibitor.
(C,D) Cells were induced to tetraploid cells with 0.5 mg/ml Cyto-B for 12 h, then were released and incubated with the indicated concentrations of the
inhibitors, tracked by live cell imaging for 40 h (*P,0.001, 262 x
2 test). Error bars are standard deviation, from results of three independent
experiments. n, the number of cells analyzed.
doi:10.1371/journal.pone.0027304.g004
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PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e27304Figure 5. Increased RhoA activity increases multipolar mitosis in tetraploid cells with wild type p53. Mitotic polarity of cells was
examined by live cell imaging after transient transfection of indicated plasmids followed by 1.5 mg/ml Cyto-B treatment for 12 h. (A,B) Selected serial
images from time-lapse records are examples of: (A) Bipolar mitosis of a 3T3 cell expressing EGFP as a control; (B) Multipolar mitosis of a 3T3 cell
expressing EGFP-RhoA-Q63L. In each image series, the upper panels (red) indicate chromosomal material, the middle panels (green) show whole cell
distribution of EGFP or cytoplasmic distribution of EGFP-RhoA-Q63L respectively, and the bottom panels show images merged with red channel,
green channel and differential interference contrast channel. Bar=10 mm. Time counted from cell entering mitosis is presented as h:min at top-left.
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randomly distributed among more than two daughter cells [18,76].
In this study, we showed that p53 abnormality could significantly
promote multipolar mitosis, leading to aneuploid daughter cells.
Actually, a recent study showed that high Aurora-A expression,
which could induce tetraploidy [66], alone is not associated with
overt multipolar mitoses, additional p53 mutations are necessary for
this to occur, at least in invasive esophageal cancer cells [77].
Although most daughter cells from multipolar mitosis would die
during the subsequent interphase or after one additional round of
mitosis [75], a small percentage of aneuploid daughter cells
inheriting a suitable genome composition could survive and even
competewithnormalcells,asobservedincellculturesandintumors
[18,76]. And this would be more realistic in p53 deficient tetraploid
cells, in which doubling of the genome increases the probability that
some daughter cells of multipolar division will have enough
chromosomestoremainviableandp53deficiencyleadstoapoptosis
resistance. Other than apoptosis, multipolar mitosis induced
aneuploid cells maybe also activate a p53-p21 driven premature
senescence phenotype. Actually, these proteins playing role in
centrosome and kinetochore integrity and in particular of
centrosomal TACC (transforming acidic coiled coil) proteins are
linked to senescence via p53 [78]. Meanwhile, these proteins also
regulate centrosome clustering and multipolar mitosis [22,79].
Taken together, here we show that p53 could not significantly
affect mitotic entry and cell death of tetraploid cells, while p53
abnormality promotes multipolar mitosis by impairing centrosome
clustering via modulation of the RhoA/ROCK signaling pathway
in tetraploid cells, leading to aneuploidy. Loss of p53 function is
favorable for the survival of aneuploid cells [80,81] and our results
described here demonstrate that loss of p53 function additionally
promotes their formation by inhibiting centrosome clustering. This
provides an alternative explanation for arising of aneuploidy
during tumour initiation and the frequent coexistence of p53
abnormalities, genomic instability, and aneuploidy in tumors.
Materials and Methods
Generation of p53
+/+ and p53
2/2 MEF
The collection and using mouse tissue were under the approval
of the Institutional Review Board at University of Science and
Technology of China, the approval ID: USTCAU201000004.
C57B1/6J mice heterozygotic for p53 were purchased from The
Jackson Laboratory. Mice were mated and at 13-days gestation,
the female was killed. Embryos were washed in PBS, the heads and
internal organs were isolated for p53 genotype analysis, and the
remainder was grinded to obtain dispersed cells. Cells were placed
on a 10-cm plate coated with 0.1% gelatin and grown in DMEM
(Gibco Life Technologies, Grand Island, NY, USA) containing
pen-strep (Gibco Life Technologies, Grand Island, NY, USA) and
10% FBS (Hyclone Labs Inc., Logan, Utah, USA) in a humid
incubator at 37uCi n5 %C O 2, as described [82]. Only passage 1
or 2 cells were used for further experiments. Cells were genotyped
by PCR according to instructions from The Jackson Laboratory.
Cell Lines
N/TERT-1 and N/TERT-1 p53DD cells were kind gifts from
James Rheinwald (Department of Dermatology, Harvard Medical
School, USA) and cultured as described [36]. HeLa cells (CCL2
from ATCC), H1299, HCT116, NIH 3T3 were cultured in
DMEM (Gibco Life Technologies, Grand Island, NY, USA)
supplemented with 10% fetal bovine serum (Hyclone Labs Inc.,
Logan, Utah, USA) and pen-strep (Gibco Life Technologies,
Grand Island, NY, USA). N/TERT-1 and N/TERT-1 p53DD
cells expressing GFP-H2B and HeLa, H1299, HCT116, 3T3 cells
expressing mCherry-H2B were created as described [37]. All cells
were maintained in a humid incubator at 37uCi n5 %C O 2.
Live cell imaging
Cancer cell lines (HeLa, H1299, and HCT116) and N/TERT-1
series cells were grown on 4-well coverglass bottom chamber (Lab-
Tek II, Nalge Nunc International, Roskilde Denmark) for 24 h or
3 d. Then cells are treated with cytochalasin B (Sigma, St. Louis,
MO, USA) for 24 h (cancer cell lines, 3 mg/ml; N/TERT-1 series,
6 mg/ml). To terminate drug treatments, cells were washed with
drug-free medium more than five times over a period of 30 min
before imaging. Images were acquired automatically at multiple
locations on the coverslips using a Nikon TE2000E inverted
microscope fitted with a 206 Nikon Plan Fluor objective (Nikon
Corporation, Tokyo, Japan), a linearly-encoded stage (Prior
Scientific Instruments Ltd., Cambridge, UK) and a Hamamatsu
Orca-ER CCD camera (Hamamatsu Photonics, Hamamatsu,
Japan). Fluorescence illumination used a mercury-arc lamp with
two neutral density filters (for a total 32-fold reduction in intensity).
The microscope was controlled using NIS-Elements Advanced
Research (Nikon Corporation, Tokyo, Japan). The microscope
was housed in a custom-designed 37uC chamber with a secondary
(C) The frequency of multipolar mitosis in tetraploid cells was increased after constitutively active RhoA expression in 3T3 cells (p53 normal)
(*P,0.001, 262 x
2 test). Error bars are standard deviation, from results of three independent experiments. n, the number of cells analyzed.
doi:10.1371/journal.pone.0027304.g005
Table 3. Centrosome clustering was enhanced in p53
-/- MEF cells with extra centrosomes after RhoA or ROCK inhibition.
No. of cells analyzed % (Mean±s.d.)
Centrosome inactivation Centrosome clustering Both Neither
Control 316 21.562.4 73.162.3 12.062.3 17.462.4
C3 transferase 284 19.763.5 86.665.3 * 14.860.7 8.563.5 *
H1152 347 25.460.9 81.063.5 * 16.761.5 10.461.4 *
p53
-/- MEF cells were treated with Cyto-B (0.5 mg/ml) for 12 h, then released and treated with 0.5 mg/ml C3 transferase (RhoA inhibitor) or 0.5 mM H1152 (ROCK inhibitor)
for 8h, and stained with antibodies against c-tubulin and a-tubulin for centrosomes and microtubules, respectively. Nuclei were stained with DAPI. Note that only cells
with more than 3 centrosomes at metaphase were analyzed. The percentage of cells with indicated mechanism was shown separately. Mean 6 s.d. from three
independent experiments.
*p,0.05, 262 x
2 test, compared with control cells.
doi:10.1371/journal.pone.0027304.t003
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and differential interference contrast images were obtained every
10,15 min for a period of 50–64 h. For MEF series, cells were
seeded on 8-well coverglass bottom chamber, coated with 0.1%
gelatin, for 24 h (2610
4 cells per well). After 0.5 mg/ml
cytochalasin B treatment for 12 h, cells were washed with drug-
free medium more than five times over a period of 30 min to
terminate drug treatments before imaging. Then images were
acquired as described above and differential interference contrast
images were obtained every 10 min for a period of 40 h. For
experiments in Fig. 4, cell permeable RhoA inhibitor C3
transferase (Cytoskeleton, Denver, CO, USA) or ROCK inhibitor
H1152 (Calbiochem, La Jolla, CA, USA) was added to the culture
medium before live cell imaging. C3 transferase was dissolved in
50% glycerol (Invitrogen, Carlsbad, CA, USA). Standard
deviations were derived from the results from at least 3
independent experiments.
Plasmid and DNA transfections
pcDNA3-EGFP and pcDNA3-EGFP RhoA-Q63L were kind
gifts from Professor Gary Bokoch (Departments of Immunology &
Microbial Science, The Scripps Research Institute, USA) [83].
pEGFP-p53 R175H was kind gift from Professor Mian Wu
(School of Life Sciences, University of Science and Technology of
China) [84]. 3T3 H2B-mCherry was seeded on 4-well coverglass
bottom chamber (1.5610
4 cells in each well) and cultured with
DMEM (10% FBS). After 24 hours, cells were transfected with
plasmid (1 mg for each well) using the Lipofectamine 2000
transfection reagent (Invitrogen, Carlsbad, CA, USA) (2 ml for
each well) following the manufacture’s protocol. Fresh medium
was added 4 hours later. Cells were cultured for 36 hours after
transfection then treated with 1.5 mg/ml cytochalasin B (Sigma,
St. Louis, MO, USA) for 12 h. To terminate drug treatments, cells
were washed with drug-free medium more than five times over a
period of 30 min before imaging. Live cell imaging were
performed as described.
RNA Interference
p53
-/- MEF cells were cultured as described previously [82].
ECT2 siRNA corresponding to nucleotide sequences 867–891
(GenBank accession no. BC045614) and the control siRNA were
chemically synthesized by Genepharma (Shanghai, China). Cells
were transfected with Lipofectamine RNAiMAX Reagent (Invi-
trogen, CA, USA) and 20 nM siRNA according to the
manufacturer’s protocol and cultured in growth medium for up
Table 4. Centrosome behavior after RhoA or ROCK inhibition
in p53
-/- MEF cells with extra centrosomes.
No. of cells
analyzed Mean±s.d.
C value Cl value I value
Control 316 1.6960.56 1.5860.53 0.0660.12
C3 transferase 284 1.9360.59 * 1.8160.58 * 0.0660.12
H1152 347 1.9060.55 * 1.7660.56 * 0.0760.13
*p,0.001, t-test, compared with the control.
doi:10.1371/journal.pone.0027304.t004
Figure 6. p53 deficiency contributes to multipolar mitosis in tetraploid cells. The model shows that p53 abnormality is a major cause for
multipolar mitosis in tetraploid cells. Specifically, we propose that a number of distinct primary cell cycle errors such as cytokinesis failure leads to
tetraploid cells with 4N DNA and two centrosomes. These cells undergo DNA replication and centrosome duplication before entering mitosis, giving
rise to octoploidy with four centrosomes. In p53 proficient cells, most of them will undergo bipolar mitosis, most likely through clustering extra
centrosomes, though a mechanism inactivating extra centrosomes may also occur. In the absence of a functional p53, however, ECT2 is
overexpressed, and then RhoA/ROCK is overactivated, which impairs the ability of clustering extra centrosomes most likely through disrupting the
arrangement of actin cytoskeleton and leads to multipolar mitosis, giving rise to chromosomal instability and aneuploidy.
doi:10.1371/journal.pone.0027304.g006
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western blotting analysis using rabbit anti-Ect2 antibody (Santa
Cruz, Santa Cruz, California, USA).
RhoA activity assay
The GST-Rhotekin which contains the RhoA interactive
domain was expressed and purified in Escherichia coli, which is
a kind gift from Professor Aihua Gong (School of Medical Science
and Laboratory Medicine, Jiangsu University, China). The Rho
GTPase activities were processed as previously described [85].
Briefly, wild-type and p53
-/- MEF cells grown in log phase were
used. After the indicated treatment, cells were lysed before
incubation with GST-Rhotekin, coupled to glutathione-agarose
beads (GE Healthcare, Piscataway, NJ, USA). After precipitation,
complexes were washed four times with wash buffer, eluted in
SDS–PAGE sample buffer, immunoblotted and analysed with
antibodies against RhoA (Santa Cruz, Santa Cruz, California,
USA). Aliquots taken from supernatants prior to precipitation
were used to quantify total RhoA present in cell lysates. All
experiments were repeated three times, and the bands were
quantified using the Gel-Pro Analyzer 4.0 computer program
(Media Cybernetics, Silver Spring, MD).
Immunofluorescence
MEF cells at passage 1 were grown on glass coverslips coated
with 0.1% gelatin for 24 h, treated with 0.5 mg/ml cytochalasin B
for 12 h to induce tetraploid cells, then released or treated with
0.5 mg/ml C3 transferase or 0.5 mM H1152 for 8 h after washing
with drug-free medium more than five times over a period of
30 min to terminate drug treatments. Then, cells were permea-
bilized with 0.5% Triton X-100 (Sigma, St. Louis, MO, USA) in
Perm buffer (100 mM PIPES (Sigma, St. Louis, MO, USA),
10 mM EGTA (BioBasic, ED0077), 1 mM MgCl2 (Sigma, St.
Louis, MO, USA)), and fixed in methanol for 30 min at 220uC.
The coverslips were hydrated in TBS/0.1% Triton X-100 (TBST)
for 365 min and blocked with 2% BSA in TBST for 1 h, then
subjected to indirect immunofluorescence with the following
primary antibodies: rabbit Abs to gamma-tubulin (Sigma, St.
Louis, MO, USA) at 1:200, mouse Abs to alpha-tubulin (Sigma,
St. Louis, MO, USA) at 1:200. The coverslips with primary
antibodies was placed in a humid chamber at 37uC for 3 h and
then washed with TBST for 3610 min. The secondary antibodies
were Alexa Fluor 488-conjugated donkey anti-mouse IgG (1:200,
Molecular Probes A21202), Alexa Fluor 555 -conjugated donkey
anti-rabbit IgG (1:100, Molecular Probes A31572) at 37uC for 2 h.
In all cases, the coverslips were counterstained with DAPI at 3 mg/
ml. Samples were scored using a BX-61 microscope (Olympus,
Osaka, Japan). At least 100 cells were scored per experiment, and
each experiment was repeated three times.
Statistical analysis
Unless otherwise specified, all experiments were carried out in
triplicate parallel instances and independently repeated at least
three times. Data were analyzed with SPSS version 10 (SPSS,
Chicago, Illinois, USA) and statistical significance was assessed by
means of two-tailed Student’s t-test or 262 x
2 test. Values of
p,0.05 were considered statistically significant.
Supporting Information
Figure S1 Etoposide increases the level of p53 and its
downstream proteins in NIH3T3 cells. Cells were seeded
and cultured in 6-well plates until at ,60% confluency, then
treated with 20 mM etoposide, an inhibitor of topoisomerase II
that induces DNA damage, for 12h. DMSO was used as a control.
Then western blotting was carried out to detect the expression of
p53 and its direct downstream protein p21and Bax, which are
related to cell cycle arrest and apoptosis respectively. b-actin was
used as a loading control.
(TIF)
Figure S2 Loss of p53 disrupts actin cytoskeleton. Cells
were plated on 0.1% gelatin-coated coverslips and cultured for
48 h and then stained with Phalloidin-TRITC to visualize the F-
actin cytoskeleton (Red). Nuclei were counterstained with DAPI
(blue).
(TIF)
Table S1 Centrosome clustering was impaired in p53-/- MEF
cells with four centrosomes.
(PDF)
Table S2 Centrosome behavior of MEF cells with four
centrosome.
(PDF)
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